A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells

Laboratory Investigation

Volumn 86, Issue 5, 2006, Pages 477-489

  Jung, Youngmi ^a   Oh, Seh Hoon ^a   Zheng, Donghang ^a   Shupe, Thomas D ^a   Witek, Rafal P ^a   Petersen, Bryon E ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hepatic oval cells; Migration; Somatostatin; Somatostatin receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; N (2 FLUORENYL)ACETAMIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

2-ACETYLAMINOFLUORENE; ANIMALS; ANTIBODIES; CARCINOGENS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; DISEASE MODELS, ANIMAL; HEPATECTOMY; HEPATOCYTES; LIVER; MALE; MEMBRANE PROTEINS; RATS; RATS, INBRED F344; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 33646155549     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700410     Document Type: Article

References (48)

1. Oh SH, Hatch HM, Petersen BE. Hepatic oval 'stem' cell in liver regeneration. Semin Cell Dev Biol 2002;13:405-409.
2. Fausto N. Liver stem cell. In: Arias ISD, Schachter D, kavoby W, Boyer J (eds). The Liver: Biology and Pathobiology. Raven: New York, 1994, p 1501.
3. Preisegger KH, Factor VM, Fuchsbichler A, et al. Atypical ductular proliferation and its inhibition by transforming growth factor betal in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 1999;79:103-109.
4. Petersen BE, Goff JP, Greenberger JS, et al. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998;27:433-445.
5. Omori N, Omori M, Evarts RP, et al. Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology 1997;26:720-727.
6. Faris RA, Monfils BA, Dunsford HA, et al. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the 'resistant hepatocyte' model system. Cancer Res 1991;51:1308-1317.
7. Hixson DC, Faris RA, Thompson NL. An antigenic portrait of the liver during carcinogenesis. Pathobiology 1990;58:65-77.
8. Yang L, Faris RA, Hixson DC. Phenotypic heterogeneity within clonogenic ductal cell populations isolated from normal adult rat liver. Proc Soc Exp Biol Med 1993;204:280-288.
9. Alison MR, Vig P, Russo F, et al. Hepatic stem cells: from inside and outside the liver? Cell Prolif 2004;37:1-21.
10. Evarts RP, Nakatsukasa H, Marsden ER, et al. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res 1990;50:3439-3444.
11. Fausto NLJ, Shiojiri N. Oval cells in liver carcinogenesis; cell lineages in hepatic development and identification of stem cells in normal liver. In: Raton SAB (ed). The Role of Cell Types in Hepatocarcinogenesis. CRC Press: Boca Raton, FL, 1992, p 89.
12. Libbrecht L, Desmet V, Van Damme B, et al. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000;192:373-378.
13. Mohle R, Bautz F, Denzlinger C, et al. Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors. Ann NY Acad Sci 2001;938:26-34; discussion 34-35.
14. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
15. Olias G, Viollet C, Kusserow H, et al. Regulation and function of somatostatin receptors. J Neurochem 2004;89:1057-1091.
16. Elliott DE, Blum AM, Li J, et al. Preprosomatostatin messenger RNA is expressed by inflammatory cells and induced by inflammatory mediators and cytokines. J Immunol 1998;160:3997-4003.
17. Bertherat J, Bluet-Pajot MT, Epelbaum J. Neuroendocrine regulation of growth hormone. Eur J Endocrinol 1995;132:12-24.
18. Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2003;2:999-1017.
19. Solomou K, Ritter MA, Palmer DB. Somatostatin is expressed in the murine thymus and enhances thymocyte development. Eur J Immunol 2002;32:1550-1559.
20. Lahlou H, Guillermet J, Hortala M, et al. Molecular signaling of somatostatin receptors. Ann NY Acad Sci 2004;1014:121-131.
21. Bruno JF, Xu Y, Song J, et al. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 1993;133:2561-2567.
22. Reynaert H, Vaeyens F, Qin H, et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001;121:915-930.
23. Song SH, Leng XS, Li T, et al. Expression of subtypes of somatostatin receptors in hepatic stellate cells. World J Gastroenterol 2004;10:1663-1665.
24. Godlewski A. Calcitonin and somatostatin immunoreactive cells are present in human bone marrow and bone marrow cells are responsive to calcitonin and somatostatin. Exp Clin Endocrinol 1990;96:219-233.
25. Oomen SP, van Hennik PB, Antonissen C, et al. Somatostatin is a selective chemoattractant for primitive (CD34(+)) hematopoietic progenitor cells. Exp Hematol 2002;30:116-125.
26. Lowes KN, Croager EJ, Olynyk JK, et al. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol 2003;18:4-12.
27. Novikoff PM, Yam A, Oikawa I. Blast-like cell compartment in carcinogen-induced proliferating bile ductules. Am J Pathol 1996;148:1473-1492.
28. Higgins GM, Anderson RM. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
29. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
30. Deng J, Steindler DA, Laywell ED, et al. Neural trans-differentiation potential of hepatic oval cells in the neonatal mouse brain. Exp Neurol 2003;182:373-382.
31. Sum EY, Shackleton M, Hahm K, et al. Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development. Oncogene 2005;24:4820-4828.
32. Bar KJ, Schurigt U, Scholze A, et al. The expression and localization of somatostatin receptors in dorsal root ganglion neurons of normal and monoarthritic rats. Neuroscience 2004;127:197-206.
33. Stolz DB, Michalopoulos GK. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro. J Cell Physiol 1997;170:57-68.
34. Rosskopf D, Schurks M, Manthey I, et al. Signal transduction of somatostatin in human B lymphoblasts. Am J Physiol Cell Physiol 2003;284:C179-C190.
35. Smalley KS, Feniuk W, Sellers LA, et al. The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidification. Biochem Biophys Res Commun 1999;263:239-243.
36. Yacubova E, Komuro H. Stage-specific control of neuronal migration by somatostatin. Nature 2002;415:77-81.
37. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279:509-514.
38. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157-198.
39. Petersen BE, Grossbard B, Hatch H, et al. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 2003;37:632-640.
40. Fiegel HC, Park JJ, Lioznov MV, et al. Characterization of cell types during rat liver development. Hepatology 2003;37:148-154.
41. Liu D, Martino G, Thangaraju M, et al. Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis. J Biol Chem 2000;275:9244-9250.
42. Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 1996;10:1688-1696.
43. Alderton F, Fan TP, Humphrey PP. Somatostatin receptor-mediated arachidonic acid mobilization: evidence for partial agonism of synthetic peptides. Br J Pharmacol 2001;132:760-766.
44. Sellers LA, Feniuk W, Humphrey PP, et al. Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. J Biol Chem 1999;274:16423-16430.
45. Rocheville M, Lange DC, Kumar U, et al. Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J Biol Chem 2000;275:7862-7869.
46. Bonig H, Priestley GV, Nilsson LM, et al. PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells. Blood 2004;104:2299-2306.
47. Papakonstanti EA, Stournaras C. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell 2002;13:2946-2962.
48. Qian Y, Zhong X, Flynn DC, et al. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling. Oncogene 2005;24:3154-3165.